Long-term pioglitazone effect on triple transgenic model of Alzheimer's disease (3xTg-AD): hippocampus
Transcriptomics Dataset
FAIR Metrics
0 evaluations
General Information
| Accession | GSE32536 |
| Title | Long-term pioglitazone effect on triple transgenic model of Alzheimer's disease (3xTg-AD): hippocampus |
| Description | Analysis of hippocampus from 10 month-old, triple-transgenic AD females treated with the thiazolidinedione pioglitazone (PIO) for 14 weeks. TZDs exert cognitive benefits early in the AD process. Results provide insight into molecular mechanisms underlying the neuroprotective role of PIO in AD. |
| Landing Page | https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32536 |
| Repository | Gene Expression Omnibus |
Tools
used to analyze the dataset
Canned Analyses
generated with the dataset
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.
